← FDA Drug Approvals (Drugs@FDA)

MESALAMINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS INC · Approved 2024-08-22

Drug application

FDA Application #

ANDA213191

Application type

Abbreviated New Drug Application (Generic)

Brand name

MESALAMINE

Generic name

MESALAMINE

Active ingredients

MESALAMINE

Dosage form

TABLET, DELAYED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

TEVA PHARMS INC

Manufacturer

Teva Pharmaceuticals, Inc.

First approval

2024-08-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown